ニュージーランドの地域薬局における不要医薬品の廃棄慣行と、定量噴霧式吸入器（pMDI）の低炭素回収スキームへの協力意向
Disposal practices for unwanted medicines in New Zealand community pharmacies and their willingness to support a low-carbon return scheme for metered-dose inhalers (原題)
Sara M. Hanning, Melissa Barnes, Rob Burrell, Trudi Aspden
🤖 gxceed AI 要約
日本語
NZの地域薬局102軒への調査で、98%が不要医薬品を回収しているが、廃棄方法は専用廃棄物ボックス・下水・一般ごみと多様で、薬剤師は廃棄後の行方を十分把握していなかった。pMDIはHFC推進剤を含み、専用回収・破壊スキームで炭素削減が可能だが、参加意向は42.7%にとどまり、管理負担とコストが障壁となった。
English
A survey of 102 New Zealand community pharmacies found 98% collect unwanted medicines, but disposal routes vary (pharmaceutical waste bins, sink, general rubbish) and staff feel poorly informed about downstream handling. pMDIs contain HFC propellants; a dedicated return-and-destroy scheme could cut their carbon footprint, yet only 42.7% expressed willingness to participate, citing administrative burden and cost.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本でも吸入器のHFC回収は未整備で、フロン排出抑制法・医療廃棄物制度との接続が論点となる。Scope 3排出量算定や医療機関の脱炭素計画を検討する日本企業・自治体にとって、廃棄段階の排出を可視化する示唆がある。
In the global GX context
This adds a healthcare-waste angle to the global decarbonization agenda, complementing HFC phase-down under the Kigali Amendment and CSRD/ISSB Scope 3 expectations. It shows how last-mile return infrastructure and staff education shape whether low-carbon schemes for medical devices actually scale.
👥 読者別の含意
🔬研究者:医療廃棄物・フロン排出とScope 3算定を接続する実証研究として、回収スキームの受容性要因を分析する枠組みを提供する。
🏢実務担当者:医療・製薬・小売のサステナビリティ担当は、pMDI等の製品回収スキーム設計時に管理負担とコストの低減策を検討する材料になる。
🏛政策担当者:HFC規制と医療廃棄物制度の接続、回収インフラ整備の政策的インセンティブ設計を検討する際の基礎資料となる。
📄 Abstract（原文）
Abstract In New Zealand, appropriate disposal of non-cytotoxic medicines involves collection, steam sterilisation and transfer to a dedicated landfill by a third-party contractor. However, little is known about whether community pharmacies routinely dispose of unwanted medicines via this process. Even when disposed of appropriately, medicines can still cause environmental harm. Pressurised metered-dose inhalers (pMDIs) pose a particular threat due to their hydrofluorocarbon (HFC) propellant gases, which remain after all doses have been used. A specialised scheme that safely captures and destroys HFCs in empty and unwanted pMDIs could significantly lower the carbon footprint of pMDI use. This study explored current pharmacy disposal practices for returned or expired medicines and the willingness of community pharmacies to participate in a dedicated pMDI return scheme. An invitation to complete an online questionnaire was emailed to community pharmacies across New Zealand. Questions examined current medicine disposal practices, willingness to be involved in a pMDI return scheme, and perceived enablers and barriers to involvement. Of the 1043 pharmacies invited to participate, 102 responses were sufficiently complete for analysis. Of these, 98% reported collecting unwanted or expired medicines for disposal. Current disposal methods included placing waste into dedicated pharmaceutical waste bins, pouring down the sink and placing with general rubbish. Regarding a pMDI return scheme, 42.7% expressed interest in participating, particularly if barriers such as the administrative burden and cost could be addressed. Increased education for pharmacy staff about pharmaceutical waste pathways and environmentally responsible disposal methods could support pharmacies to adopt practices more protective of planetary health. Graphical abstract Community pharmacies reported disposing of unwanted medicines via third-party contractors, down the sink or with general waste. Pharmacists reported feeling poorly informed about what happens to the waste when it leaves the pharmacy. A dedicated return scheme for pressurised metered-dose inhalers (pMDIs) could capture and destroy propellant gases.
🔗 Provenance — このレコードを発見したソース
- openalex https://doi.org/10.1007/s10098-026-03622-5first seen 2026-10-06 05:03:14
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。